Artiva Biotherapeutics, Inc. (ARTV) Current Reports & Earnings Releases
Upcoming
- 2026-11-11 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-22 | 8-K | Other Events | SEC |
| 2026-05-19 | 8-K | Officer / Director Changes | SEC |
| 2026-05-08 | 8-K | Results of Operations, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-24 | 8-K | Officer / Director Changes | SEC |
| 2026-02-19 | 8-K | Officer / Director Changes | SEC |
| 2025-12-12 | 8-K | Officer / Director Changes | SEC |
| 2025-11-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-12 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-25 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-24 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-01-29 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-11-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-22 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-08-29 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-07-22 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.